カテゴリ： 世界, 医療/バイオ, QYResearch

エピルビシン塩酸塩注射液の世界市場2023年：5mg、10mg

■ 英語タイトル：Global Epirubicin Hydrochloride Injection Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8753）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8753
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[エピルビシン塩酸塩注射液の世界市場2023年：5mg、10mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はエピルビシン塩酸塩注射液のグローバル市場について調査・分析し、世界のエピルビシン塩酸塩注射液市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（5mg、10mg）、用途別セグメント分析（白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Akorn、Aurobindo Pharma、Cipla、Ebewe Pharma、Fresenius Kabi Usa、Impax Laboratories、Mylan Laboratories、Nippon Kayaku、Pfizer、Sawai Pharmaceutical、Zennova、Beijing Union Pharmaceutical Factory、Hisun Pharmaceutical、Hanhui Pharmaceutical、Lunan Pharmaceuticalなどが含まれています。エピルビシン塩酸塩注射液のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、エピルビシン塩酸塩注射液市場規模を算出する際に考慮しました。

・エピルビシン塩酸塩注射液市場の概要
- 製品の定義
- エピルビシン塩酸塩注射液の種類別セグメント
- 世界のエピルビシン塩酸塩注射液市場規模：タイプ別分析（5mg、10mg）
- エピルビシン塩酸塩注射液の用途別セグメント
- 世界のエピルビシン塩酸塩注射液市場規模：用途別分析（白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他）
- 世界のエピルビシン塩酸塩注射液市場規模予測（2018年-2029年）
- エピルビシン塩酸塩注射液の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- エピルビシン塩酸塩注射液市場の競争状況およびトレンド

・エピルビシン塩酸塩注射液の地域別市場規模
- 北米のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 米国のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- ヨーロッパのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- アジア太平洋のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中国のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 日本のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 韓国のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- インドのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- オーストラリアのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中南米のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中東・アフリカのエピルビシン塩酸塩注射液市場規模（2018年-2029年）

・種類別セグメント：5mg、10mg
- 世界のエピルビシン塩酸塩注射液のタイプ別販売量（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液のタイプ別売上（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液のタイプ別価格

・用途別セグメント：白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他
- 世界のエピルビシン塩酸塩注射液の用途別販売量（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液の用途別売上（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Akorn、Aurobindo Pharma、Cipla、Ebewe Pharma、Fresenius Kabi Usa、Impax Laboratories、Mylan Laboratories、Nippon Kayaku、Pfizer、Sawai Pharmaceutical、Zennova、Beijing Union Pharmaceutical Factory、Hisun Pharmaceutical、Hanhui Pharmaceutical、Lunan Pharmaceutical

・産業チェーンと販売チャネルの分析
- エピルビシン塩酸塩注射液産業チェーン分析
- エピルビシン塩酸塩注射液の主要原材料
- エピルビシン塩酸塩注射液の販売チャネル
- エピルビシン塩酸塩注射液のディストリビューター
- エピルビシン塩酸塩注射液の主要顧客

・エピルビシン塩酸塩注射液市場ダイナミクス
- エピルビシン塩酸塩注射液の業界動向
- エピルビシン塩酸塩注射液市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Epirubicin Hydrochloride Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Epirubicin Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Epirubicin Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Epirubicin Hydrochloride Injection include Akorn, Aurobindo Pharma, Cipla, Ebewe Pharma, Fresenius Kabi Usa, Impax Laboratories, Mylan Laboratories, Nippon Kayaku and Pfizer, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Epirubicin Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epirubicin Hydrochloride Injection.
The Epirubicin Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Epirubicin Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epirubicin Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
Segment by Type
5mg
10mg
Segment by Application
Leukemia
Malignant Lymphoma
Multiple Myeloma
Breast Cancer
Lung Cancer
Soft Tissue Sarcoma
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epirubicin Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epirubicin Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Epirubicin Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Epirubicin Hydrochloride Injection
1.2 Epirubicin Hydrochloride Injection Segment by Type
1.2.1 Global Epirubicin Hydrochloride Injection Market Value Comparison by Type (2023-2029)
1.2.2 5mg
1.2.3 10mg
1.3 Epirubicin Hydrochloride Injection Segment by Application
1.3.1 Global Epirubicin Hydrochloride Injection Market Value by Application: (2023-2029)
1.3.2 Leukemia
1.3.3 Malignant Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Lung Cancer
1.3.7 Soft Tissue Sarcoma
1.3.8 Stomach Cancer
1.3.9 Colorectal Cancer
1.3.10 Ovarian Cancer
1.3.11 Others
1.4 Global Epirubicin Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Epirubicin Hydrochloride Injection Revenue 2018-2029
1.4.2 Global Epirubicin Hydrochloride Injection Sales 2018-2029
1.4.3 Global Epirubicin Hydrochloride Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Epirubicin Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Epirubicin Hydrochloride Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Epirubicin Hydrochloride Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Epirubicin Hydrochloride Injection Average Price by Manufacturers (2018-2023)
2.4 Global Epirubicin Hydrochloride Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Product Type & Application
2.7 Epirubicin Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Epirubicin Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epirubicin Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Epirubicin Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epirubicin Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Epirubicin Hydrochloride Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Epirubicin Hydrochloride Injection Global Epirubicin Hydrochloride Injection Sales by Region: 2018-2029
3.2.1 Global Epirubicin Hydrochloride Injection Sales by Region: 2018-2023
3.2.2 Global Epirubicin Hydrochloride Injection Sales by Region: 2024-2029
3.3 Global Epirubicin Hydrochloride Injection Global Epirubicin Hydrochloride Injection Revenue by Region: 2018-2029
3.3.1 Global Epirubicin Hydrochloride Injection Revenue by Region: 2018-2023
3.3.2 Global Epirubicin Hydrochloride Injection Revenue by Region: 2024-2029
3.4 North America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.4.3 North America Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.5.3 Europe Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.7.3 Latin America Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Epirubicin Hydrochloride Injection Sales by Type (2018-2029)
4.1.1 Global Epirubicin Hydrochloride Injection Sales by Type (2018-2023)
4.1.2 Global Epirubicin Hydrochloride Injection Sales by Type (2024-2029)
4.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Type (2018-2029)
4.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2018-2029)
4.2.1 Global Epirubicin Hydrochloride Injection Revenue by Type (2018-2023)
4.2.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2024-2029)
4.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Type (2018-2029)
4.3 Global Epirubicin Hydrochloride Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Epirubicin Hydrochloride Injection Sales by Application (2018-2029)
5.1.1 Global Epirubicin Hydrochloride Injection Sales by Application (2018-2023)
5.1.2 Global Epirubicin Hydrochloride Injection Sales by Application (2024-2029)
5.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Application (2018-2029)
5.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2018-2029)
5.2.1 Global Epirubicin Hydrochloride Injection Revenue by Application (2018-2023)
5.2.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2024-2029)
5.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Application (2018-2029)
5.3 Global Epirubicin Hydrochloride Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Akorn
6.1.1 Akorn Corporation Information
6.1.2 Akorn Description and Business Overview
6.1.3 Akorn Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Akorn Epirubicin Hydrochloride Injection Product Portfolio
6.1.5 Akorn Recent Developments/Updates
6.2 Aurobindo Pharma
6.2.1 Aurobindo Pharma Corporation Information
6.2.2 Aurobindo Pharma Description and Business Overview
6.2.3 Aurobindo Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aurobindo Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.2.5 Aurobindo Pharma Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cipla Epirubicin Hydrochloride Injection Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Ebewe Pharma
6.4.1 Ebewe Pharma Corporation Information
6.4.2 Ebewe Pharma Description and Business Overview
6.4.3 Ebewe Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ebewe Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.4.5 Ebewe Pharma Recent Developments/Updates
6.5 Fresenius Kabi Usa
6.5.1 Fresenius Kabi Usa Corporation Information
6.5.2 Fresenius Kabi Usa Description and Business Overview
6.5.3 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Product Portfolio
6.5.5 Fresenius Kabi Usa Recent Developments/Updates
6.6 Impax Laboratories
6.6.1 Impax Laboratories Corporation Information
6.6.2 Impax Laboratories Description and Business Overview
6.6.3 Impax Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Impax Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.6.5 Impax Laboratories Recent Developments/Updates
6.7 Mylan Laboratories
6.6.1 Mylan Laboratories Corporation Information
6.6.2 Mylan Laboratories Description and Business Overview
6.6.3 Mylan Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.7.5 Mylan Laboratories Recent Developments/Updates
6.8 Nippon Kayaku
6.8.1 Nippon Kayaku Corporation Information
6.8.2 Nippon Kayaku Description and Business Overview
6.8.3 Nippon Kayaku Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nippon Kayaku Epirubicin Hydrochloride Injection Product Portfolio
6.8.5 Nippon Kayaku Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Epirubicin Hydrochloride Injection Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Sawai Pharmaceutical
6.10.1 Sawai Pharmaceutical Corporation Information
6.10.2 Sawai Pharmaceutical Description and Business Overview
6.10.3 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.10.5 Sawai Pharmaceutical Recent Developments/Updates
6.11 Zennova
6.11.1 Zennova Corporation Information
6.11.2 Zennova Epirubicin Hydrochloride Injection Description and Business Overview
6.11.3 Zennova Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zennova Epirubicin Hydrochloride Injection Product Portfolio
6.11.5 Zennova Recent Developments/Updates
6.12 Beijing Union Pharmaceutical Factory
6.12.1 Beijing Union Pharmaceutical Factory Corporation Information
6.12.2 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Description and Business Overview
6.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Product Portfolio
6.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.13 Hisun Pharmaceutical
6.13.1 Hisun Pharmaceutical Corporation Information
6.13.2 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.13.3 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.13.5 Hisun Pharmaceutical Recent Developments/Updates
6.14 Hanhui Pharmaceutical
6.14.1 Hanhui Pharmaceutical Corporation Information
6.14.2 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.14.3 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.14.5 Hanhui Pharmaceutical Recent Developments/Updates
6.15 Lunan Pharmaceutical
6.15.1 Lunan Pharmaceutical Corporation Information
6.15.2 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.15.3 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.15.5 Lunan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epirubicin Hydrochloride Injection Industry Chain Analysis
7.2 Epirubicin Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epirubicin Hydrochloride Injection Production Mode & Process
7.4 Epirubicin Hydrochloride Injection Sales and Marketing
7.4.1 Epirubicin Hydrochloride Injection Sales Channels
7.4.2 Epirubicin Hydrochloride Injection Distributors
7.5 Epirubicin Hydrochloride Injection Customers
8 Epirubicin Hydrochloride Injection Market Dynamics
8.1 Epirubicin Hydrochloride Injection Industry Trends
8.2 Epirubicin Hydrochloride Injection Market Drivers
8.3 Epirubicin Hydrochloride Injection Market Challenges
8.4 Epirubicin Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Epirubicin Hydrochloride Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Epirubicin Hydrochloride Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Epirubicin Hydrochloride Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Epirubicin Hydrochloride Injection Sales (K L) of Key Manufacturers (2018-2023)
Table 5. Global Epirubicin Hydrochloride Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Epirubicin Hydrochloride Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Epirubicin Hydrochloride Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Epirubicin Hydrochloride Injection Average Price (US$/L) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Epirubicin Hydrochloride Injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Epirubicin Hydrochloride Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Epirubicin Hydrochloride Injection, Product Type & Application
Table 12. Global Key Manufacturers of Epirubicin Hydrochloride Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Epirubicin Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epirubicin Hydrochloride Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Epirubicin Hydrochloride Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Epirubicin Hydrochloride Injection Sales by Region (2018-2023) & (K L)
Table 18. Global Epirubicin Hydrochloride Injection Sales Market Share by Region (2018-2023)
Table 19. Global Epirubicin Hydrochloride Injection Sales by Region (2024-2029) & (K L)
Table 20. Global Epirubicin Hydrochloride Injection Sales Market Share by Region (2024-2029)
Table 21. Global Epirubicin Hydrochloride Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Epirubicin Hydrochloride Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Epirubicin Hydrochloride Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Epirubicin Hydrochloride Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Epirubicin Hydrochloride Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Epirubicin Hydrochloride Injection Sales by Country (2018-2023) & (K L)
Table 27. North America Epirubicin Hydrochloride Injection Sales by Country (2024-2029) & (K L)
Table 28. North America Epirubicin Hydrochloride Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Epirubicin Hydrochloride Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Epirubicin Hydrochloride Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Epirubicin Hydrochloride Injection Sales by Country (2018-2023) & (K L)
Table 32. Europe Epirubicin Hydrochloride Injection Sales by Country (2024-2029) & (K L)
Table 33. Europe Epirubicin Hydrochloride Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Epirubicin Hydrochloride Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Epirubicin Hydrochloride Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Epirubicin Hydrochloride Injection Sales by Region (2018-2023) & (K L)
Table 37. Asia Pacific Epirubicin Hydrochloride Injection Sales by Region (2024-2029) & (K L)
Table 38. Asia Pacific Epirubicin Hydrochloride Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Epirubicin Hydrochloride Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Epirubicin Hydrochloride Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Epirubicin Hydrochloride Injection Sales by Country (2018-2023) & (K L)
Table 42. Latin America Epirubicin Hydrochloride Injection Sales by Country (2024-2029) & (K L)
Table 43. Latin America Epirubicin Hydrochloride Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Epirubicin Hydrochloride Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Epirubicin Hydrochloride Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Epirubicin Hydrochloride Injection Sales by Country (2018-2023) & (K L)
Table 47. Middle East & Africa Epirubicin Hydrochloride Injection Sales by Country (2024-2029) & (K L)
Table 48. Middle East & Africa Epirubicin Hydrochloride Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Epirubicin Hydrochloride Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Epirubicin Hydrochloride Injection Sales (K L) by Type (2018-2023)
Table 51. Global Epirubicin Hydrochloride Injection Sales (K L) by Type (2024-2029)
Table 52. Global Epirubicin Hydrochloride Injection Sales Market Share by Type (2018-2023)
Table 53. Global Epirubicin Hydrochloride Injection Sales Market Share by Type (2024-2029)
Table 54. Global Epirubicin Hydrochloride Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Epirubicin Hydrochloride Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Epirubicin Hydrochloride Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Epirubicin Hydrochloride Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Epirubicin Hydrochloride Injection Price (US$/L) by Type (2018-2023)
Table 59. Global Epirubicin Hydrochloride Injection Price (US$/L) by Type (2024-2029)
Table 60. Global Epirubicin Hydrochloride Injection Sales (K L) by Application (2018-2023)
Table 61. Global Epirubicin Hydrochloride Injection Sales (K L) by Application (2024-2029)
Table 62. Global Epirubicin Hydrochloride Injection Sales Market Share by Application (2018-2023)
Table 63. Global Epirubicin Hydrochloride Injection Sales Market Share by Application (2024-2029)
Table 64. Global Epirubicin Hydrochloride Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Epirubicin Hydrochloride Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Epirubicin Hydrochloride Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Epirubicin Hydrochloride Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Epirubicin Hydrochloride Injection Price (US$/L) by Application (2018-2023)
Table 69. Global Epirubicin Hydrochloride Injection Price (US$/L) by Application (2024-2029)
Table 70. Akorn Corporation Information
Table 71. Akorn Description and Business Overview
Table 72. Akorn Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 73. Akorn Epirubicin Hydrochloride Injection Product
Table 74. Akorn Recent Developments/Updates
Table 75. Aurobindo Pharma Corporation Information
Table 76. Aurobindo Pharma Description and Business Overview
Table 77. Aurobindo Pharma Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 78. Aurobindo Pharma Epirubicin Hydrochloride Injection Product
Table 79. Aurobindo Pharma Recent Developments/Updates
Table 80. Cipla Corporation Information
Table 81. Cipla Description and Business Overview
Table 82. Cipla Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Cipla Epirubicin Hydrochloride Injection Product
Table 84. Cipla Recent Developments/Updates
Table 85. Ebewe Pharma Corporation Information
Table 86. Ebewe Pharma Description and Business Overview
Table 87. Ebewe Pharma Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Ebewe Pharma Epirubicin Hydrochloride Injection Product
Table 89. Ebewe Pharma Recent Developments/Updates
Table 90. Fresenius Kabi Usa Corporation Information
Table 91. Fresenius Kabi Usa Description and Business Overview
Table 92. Fresenius Kabi Usa Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Fresenius Kabi Usa Epirubicin Hydrochloride Injection Product
Table 94. Fresenius Kabi Usa Recent Developments/Updates
Table 95. Impax Laboratories Corporation Information
Table 96. Impax Laboratories Description and Business Overview
Table 97. Impax Laboratories Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Impax Laboratories Epirubicin Hydrochloride Injection Product
Table 99. Impax Laboratories Recent Developments/Updates
Table 100. Mylan Laboratories Corporation Information
Table 101. Mylan Laboratories Description and Business Overview
Table 102. Mylan Laboratories Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Mylan Laboratories Epirubicin Hydrochloride Injection Product
Table 104. Mylan Laboratories Recent Developments/Updates
Table 105. Nippon Kayaku Corporation Information
Table 106. Nippon Kayaku Description and Business Overview
Table 107. Nippon Kayaku Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 108. Nippon Kayaku Epirubicin Hydrochloride Injection Product
Table 109. Nippon Kayaku Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 113. Pfizer Epirubicin Hydrochloride Injection Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Sawai Pharmaceutical Corporation Information
Table 116. Sawai Pharmaceutical Description and Business Overview
Table 117. Sawai Pharmaceutical Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 118. Sawai Pharmaceutical Epirubicin Hydrochloride Injection Product
Table 119. Sawai Pharmaceutical Recent Developments/Updates
Table 120. Zennova Corporation Information
Table 121. Zennova Description and Business Overview
Table 122. Zennova Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 123. Zennova Epirubicin Hydrochloride Injection Product
Table 124. Zennova Recent Developments/Updates
Table 125. Beijing Union Pharmaceutical Factory Corporation Information
Table 126. Beijing Union Pharmaceutical Factory Description and Business Overview
Table 127. Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 128. Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Product
Table 129. Beijing Union Pharmaceutical Factory Recent Developments/Updates
Table 130. Hisun Pharmaceutical Corporation Information
Table 131. Hisun Pharmaceutical Description and Business Overview
Table 132. Hisun Pharmaceutical Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 133. Hisun Pharmaceutical Epirubicin Hydrochloride Injection Product
Table 134. Hisun Pharmaceutical Recent Developments/Updates
Table 135. Hanhui Pharmaceutical Corporation Information
Table 136. Hanhui Pharmaceutical Description and Business Overview
Table 137. Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 138. Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Product
Table 139. Hanhui Pharmaceutical Recent Developments/Updates
Table 140. Lunan Pharmaceutical Corporation Information
Table 141. Lunan Pharmaceutical Description and Business Overview
Table 142. Lunan Pharmaceutical Epirubicin Hydrochloride Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 143. Lunan Pharmaceutical Epirubicin Hydrochloride Injection Product
Table 144. Lunan Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Epirubicin Hydrochloride Injection Distributors List
Table 148. Epirubicin Hydrochloride Injection Customers List
Table 149. Epirubicin Hydrochloride Injection Market Trends
Table 150. Epirubicin Hydrochloride Injection Market Drivers
Table 151. Epirubicin Hydrochloride Injection Market Challenges
Table 152. Epirubicin Hydrochloride Injection Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Epirubicin Hydrochloride Injection
Figure 2. Global Epirubicin Hydrochloride Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Epirubicin Hydrochloride Injection Market Share by Type in 2022 & 2029
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Epirubicin Hydrochloride Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Epirubicin Hydrochloride Injection Market Share by Application in 2022 & 2029
Figure 8. Leukemia
Figure 9. Malignant Lymphoma
Figure 10. Multiple Myeloma
Figure 11. Breast Cancer
Figure 12. Lung Cancer
Figure 13. Soft Tissue Sarcoma
Figure 14. Stomach Cancer
Figure 15. Colorectal Cancer
Figure 16. Ovarian Cancer
Figure 17. Others
Figure 18. Global Epirubicin Hydrochloride Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Epirubicin Hydrochloride Injection Market Size (2018-2029) & (US$ Million)
Figure 20. Global Epirubicin Hydrochloride Injection Sales (2018-2029) & (K L)
Figure 21. Global Epirubicin Hydrochloride Injection Average Price (US$/L) & (2018-2029)
Figure 22. Epirubicin Hydrochloride Injection Report Years Considered
Figure 23. Epirubicin Hydrochloride Injection Sales Share by Manufacturers in 2022
Figure 24. Global Epirubicin Hydrochloride Injection Revenue Share by Manufacturers in 2022
Figure 25. The Global 5 and 10 Largest Epirubicin Hydrochloride Injection Players: Market Share by Revenue in 2022
Figure 26. Epirubicin Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 27. Global Epirubicin Hydrochloride Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 28. North America Epirubicin Hydrochloride Injection Sales Market Share by Country (2018-2029)
Figure 29. North America Epirubicin Hydrochloride Injection Revenue Market Share by Country (2018-2029)
Figure 30. U.S. Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Epirubicin Hydrochloride Injection Sales Market Share by Country (2018-2029)
Figure 33. Europe Epirubicin Hydrochloride Injection Revenue Market Share by Country (2018-2029)
Figure 34. Germany Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Epirubicin Hydrochloride Injection Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific Epirubicin Hydrochloride Injection Revenue Market Share by Region (2018-2029)
Figure 41. China Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Taiwan Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Philippines Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Epirubicin Hydrochloride Injection Sales Market Share by Country (2018-2029)
Figure 52. Latin America Epirubicin Hydrochloride Injection Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Epirubicin Hydrochloride Injection Sales Market Share by Country (2018-2029)
Figure 57. Middle East & Africa Epirubicin Hydrochloride Injection Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. U.A.E Epirubicin Hydrochloride Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Sales Market Share of Epirubicin Hydrochloride Injection by Type (2018-2029)
Figure 62. Global Revenue Market Share of Epirubicin Hydrochloride Injection by Type (2018-2029)
Figure 63. Global Epirubicin Hydrochloride Injection Price (US$/L) by Type (2018-2029)
Figure 64. Global Sales Market Share of Epirubicin Hydrochloride Injection by Application (2018-2029)
Figure 65. Global Revenue Market Share of Epirubicin Hydrochloride Injection by Application (2018-2029)
Figure 66. Global Epirubicin Hydrochloride Injection Price (US$/L) by Application (2018-2029)
Figure 67. Epirubicin Hydrochloride Injection Value Chain
Figure 68. Epirubicin Hydrochloride Injection Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ロベリン塩酸塩注射液の世界市場2023年：3mg/ml、10mg/ml
  • メタラミノール酒石酸塩注射のグローバル市場展望 2023年-2029年：1ml:10mg、2ml:4mg
  • オメプラゾール腸溶性カプセルの世界市場2023年：10mg/本、20mg/本
  • グルクロラクトン錠剤のグローバル市場展望 2023年-2029年：50mg、10mg
  • ダルファンプリジンのグローバル市場展望 2023年-2029年：10mg、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8753 )"エピルビシン塩酸塩注射液の世界市場2023年：5mg、10mg" (英文：Global Epirubicin Hydrochloride Injection Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。